The Therapy Acceleration Program (TAP) is an initiative designed to speed up the development of new cancer therapies. This program aims to bridge the gap between basic research and clinical application, making promising treatments available to patients more quickly. TAP often involves partnerships between academic institutions, pharmaceutical companies, and non-profit organizations.
